Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Viagra “Value Card” Offers Buy-Six-Get-One-Free Script Deal

Executive Summary

Pfizer's Viagra "Value Card" offers patients a free prescription of the erectile dysfunction disorder drug after every six they buy

You may also be interested in...



“Cialis Challenge”: ED Drug Sampling Hides True Market Growth, Icos Says

Increased prescription sampling within the erectile dysfunction market has caused an understatement of the category's overall growth, Icos VP-Sales & Marketing Leonard Blum told investors May 3

“Cialis Challenge”: ED Drug Sampling Hides True Market Growth, Icos Says

Increased prescription sampling within the erectile dysfunction market has caused an understatement of the category's overall growth, Icos VP-Sales & Marketing Leonard Blum told investors May 3

Viagra Scripts Rebounding, Pfizer Says; Will “Recreational” Users Return?

Pfizer's Viagra "Value Card" program is already driving a rebound in prescription market share, the company maintained during its April 20 earnings call

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel